Detalhe da pesquisa
1.
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5-17 Years - VISION Network, 10 States, April 2021-January 2022.
MMWR Morb Mortal Wkly Rep
; 71(9): 352-358, 2022 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35239634
2.
Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents.
Pediatrics
; 151(5)2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026401